image imagewidth (px) 258 933 | latex stringlengths 198 5.27k | filename stringlengths 18 19 |
|---|---|---|
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Sample} & \textbf{2 days} & \textbf{3 days} & \textbf{4 days} & \textbf{5 days} & \textbf{6 days} & \textbf{Resting cell} \\
\hline
260/280 & 2.18 & 2.16 & 2.13 & 1.97 & 2.09 & 2.00 \\
\hline
260/230 & 1.61 & 1.57 & 1.65 & 1.41 & 1.60 & 1.52... | PMC5101243_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Tissue} & \textbf{Treatment} & \textbf{CFU/g tissue a} & \textbf{\#animals detection qPCR K88} \\
\hline
Colon & T1 & 1.21 $\times$ 104 $\pm$ 2.6 $\times$ 104 & 5/6 b \\
\hline
& T2 & 1.06 $\times$ 103 $\pm$ 1.93 $\times$ 103 & 4/6 \\
\hline
& T... | PMC5688758_table_10 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{3}{|l|}{\textbf{Myocardial injury}} & \multicolumn{3}{|l|}{\textbf{Mortality at 28 days}} & \multicolumn{3}{|l|}{\textbf{Mortality at 7 days}} \\
\hline
& \textbf{No (n = 21)} & \textbf{Yes (n = 26)} & \textbf{P value} & \text... | PMC4899903_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Strain} & \textbf{Protein name (No.)A} & \multicolumn{3}{|l|}{\textbf{Repeat range}} & \multicolumn{2}{|l|}{\textbf{Variation siteB}} & \multicolumn{4}{|l|}{\textbf{Variation distributionC}} \\
\hline
& & \textbf{Smallest} & \textb... | PMC3324548_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
& \textbf{FS} & \textbf{SS} & \textbf{Control} & \textbf{ANOVA} & \textbf{Tukey’s HSD test} \\
\hline
\multicolumn{6}{|l|}{WAIS-RC} \\
\hline
Verbal IQ & 93.67 (13.97) & 93.95 (14.75) & 110.52 (13.93) & F = 79.45** & FS-control p $<$ 0.001** \\
\hlin... | PMC5007652_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Gene modules} & \textbf{Method} & \textbf{Mean Squared Error} & \textbf{\# predictors of} & \textbf{Proportion of explained(\%) variance} & \textbf{\# eQTLs of} & \textbf{\# with gene of eQTLs known locations} & \textbf{Proportion of (\%) ... | PMC5155383_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
& & & \textbf{MAF} & \multicolumn{3}{|l|}{\textbf{Leprosy per se}} & \multicolumn{3}{|l|}{\textbf{MB}} & \multicolumn{3}{|l|}{\textbf{PB}} & \textbf{RegulomeDB} \\
\hline
\textbf{SNP ID} & \textbf{Population*} & \textbf{Allele} & \t... | PMC5120299_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Study} & \textbf{Outcome} & \textbf{Relative Risk/Incident Density Ratio (95\% CI)} \\
\hline
Luby, Agboatwalla et al 2004 [50] & Diarrhoea \\
\hline
RCT & Mean Incidence \\
\hline
Quality Score 6a & Antibiotic Soap & 0.50 (0.36, 0.63) \\
\hline
& ... | PMC2397399_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Strabisme} & \textbf{Effectif} & \textbf{Pourcentage} \\
\hline
Présent & 102 & 0,5 \\
\hline
Absent & 20509 & 99,66 \\
\hline
Total & 20579 & 100 \\
\hline
\end{tabular}}
\end{table} | PMC4725652_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Covariate} & \textbf{Univariate p-value} & \textbf{Overall Multivariate p-value Survival} & \textbf{HR Multivariate (CI 95\%)} \\
\hline
\\
\hline
\\
\hline
\multicolumn{4}{|l|}{IPSS-R} \\
\hline
(Very poor/Poor/Intermediate vs. other) & $<$0.00... | PMC5058695_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Species} & \textbf{Dose, kJ/m2} & \textbf{Individuals irradiated, n} & \textbf{Total eggs, n} & \textbf{Total n eggs hatched,} & \textbf{Hatchability} \\
\hline
H. dujardini & 0 & 38 & 2655 & 2199 & 0.83 \\
\hline
& 2.5 & 39 & 0 & 0 & n/a \\
... | PMC3675078_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
& \textbf{No of cases among childless men (vs fathers)} & \textbf{OR (95\% CI)} \\
\hline
Hyperglycaemia* & 88 (335) & 1.59 (1.21 to 2.08) \\
\hline
Hypo-HDL cholesterolaemia† & 102 (670) & 0.78 (0.60 to 1.01) \\
\hline
Hyperlipidaemia‡ & 97 (515) & 1.04 (... | PMC6104745_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Obstetric danger sign} & \textbf{n (\%)} \\
\hline
\multicolumn{2}{|l|}{During Pregnancy} \\
\hline
High fever & 157 (21.6) \\
\hline
Severe abdominal pain & 107 (14.7) \\
\hline
Excessive vaginal bleeding & 79 (10.1) \\
\hline
Fits during pregnancy &... | PMC4423869_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
& \textbf{C1} & \textbf{C2} & \textbf{C3} & \textbf{C4} & \textbf{C5} & \textbf{C6} \\
\hline
Overall (n = 41) & 0 & 19 & 7 & 10 & 0 & 5 \\
\hline
GSV* (n = 34) & 0 & 18 & 6 & 8 & 0 & 2 \\
\hline
SSV** (n = 7) & 0 & 1 & 1 & 2 & 0 & 3 \\
\hline
\end... | PMC5829688_table_8 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Accession no} & \textbf{Symbol} & \textbf{Gene Name} & \textbf{Reference} \\
\hline
\multicolumn{4}{|l|}{Chemokines and receptors} \\
\hline
[genebank:NM_002983] & CCL3 & Chemokine, CC motif, Ligand 3 $\pi$ & [25] \\
\hline
[genebank:NM_002984] & ... | PMC1781469_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Grade group} & \textbf{Math anxiety level} & \multicolumn{3}{|l|}{\textbf{Mean RT (ms)}} & \multicolumn{3}{|l|}{\textbf{Accuracy (\%)}} \\
\hline
& & \textbf{C1} & \textbf{C2} & \textbf{C3} & \textbf{C1} & \textbf{C2} & \textbf{C3} \\
\h... | PMC5067409_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Layer} & \textbf{Vlo} & \textbf{ny} & \textbf{R2} & \textbf{Jmo} & \textbf{ny} & \textbf{R2} \\
\hline
15 & 8.20z 88.62 $\pm$ & 5 & 0.76 & 175.42 13.17 $\pm$ & 5 & 0.71 \\
\hline
13 & 81.72 5.74 $\pm$ & 5 & 0.83 & 123.97 9.77 $\pm$ & 5 & 0.7... | PMC5016622_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{7}{|l|}{\textbf{UCP2 Genotype}} \\
\hline
& \textbf{n} & \textbf{AA} & \textbf{n} & \textbf{GA} & \textbf{n} & \textbf{GG} & \textbf{p} \\
\hline
Gender (M/F) & 140 & 102/38(72.9\%M) & 410 & 309/101(75.4\%M) & 351 & 292/59 (83.2\%... | PMC2702310_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{No} & \textbf{Age} & \textbf{Sex} & \textbf{Surgery} & \textbf{Emergency} & \textbf{Initial symptoms/findings} & \textbf{Duration between Surgery} & \multicolumn{5}{|l|}{\textbf{Patient state at the onset of NOMI}} & \textbf{Resu... | PMC6240249_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{BUILD Period} & \textbf{SEM/YR} & \textbf{BTP Trainees} & \textbf{Comment} \\
\hline
1 & SR 15 & Build Math SURF Preparation – a Attendance Bridge to Success (BBS) & Establishing Math BBS exploration, Group – 106 Career Research – a Algebra the st... | PMC5773890_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
& \multicolumn{6}{|l|}{\textbf{Quintile of the CHEI}} \\
\hline
\textbf{Selected Food Groups} & \textbf{(n = Q1 2494)} & \textbf{(n = Q2 2495)} & \textbf{(n = Q3 2495)} & \textbf{(n = Q4 2495)} & \textbf{(n = Q5 2494)} & \textbf{P for Trend 1} \\
\... | PMC5852690_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Primer No.} & \textbf{Primer Sequence (59-39)} & \textbf{Strain designation} & \textbf{Mutation} \\
\hline
1 & ATT CCC GGG TTT GAC TCT ATC TAG TGT CAG & BSU 689 & D(G123-L138) \\
\hline
2 & ATA CCC GGG GCG ACA GTT TAT GAC CCA C \\
\hline
3 & GCC G... | PMC3691195_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
& \textbf{Total patients number of} & \textbf{65 n CDI1 (3.1) (\%)} & \textbf{value2 p} \\
\hline
\\
\hline
\\
\hline
\multicolumn{4}{|l|}{Type of malignancy} \\
\hline
Acute myeloid leukaemia no remission (C92)3 & 154 & 11 (7.1) & .003 \\
\hline
Acute... | PMC4912117_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Parameter of interest} & \textbf{No acute kidney injury (n = 362)} & \textbf{Risk class (n = 165)} & \textbf{Injury class (n = 71)} & \textbf{Failure class (n = 80)} & \textbf{Loss or end-stage renal disease (n = 44)} \\
\hline
Mean age (years... | PMC3504819_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Effect} & \textbf{Pillai(df)} & \textbf{Approximate F(df)} & \textbf{P-value} \\
\hline
Age & 0.99(1) & 48.28 (25,9) & ,0.0001 \\
\hline
Experience & 0.76(1) & 1.17 (25,9) & 0.43 \\
\hline
Age*Experience & 0.87(1) & 2.46(25,9) & 0.08 \\
\hline
\en... | PMC2702002_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\multicolumn{3}{|l|}{\textbf{Obstetric characteristics}} \\
\hline
\textbf{Gestation in weeks} & \textbf{38 + 6} & \textbf{(37 + 6–39 + 2)} \\
\hline
Primiparous & 6 & (18.8) \\
\hline
Multiparous & 26 & (81.2) \\
\hline
\multicolumn{3}{|l|}{Primary indicat... | PMC5723065_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Variable} & \textbf{Study subjects with UI (n = 1,777)} & \textbf{Aa Control group (n = 8,885)} & \textbf{Bb Control group (n = 8,885)} & \textbf{Cc Control group (n = 8,885)} & \textbf{p-value 1} & \textbf{p-value 2} & \textbf{p-value 3} ... | PMC4990176_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{“CIT program number”} & \textbf{Pulse repetition rates (Hz)} \\
\hline
4 & 10.0 \\
\hline
16 & 16.0 \\
\hline
10 & 20.6 \\
\hline
18 & 23.8 \\
\hline
20 & 26.0 \\
\hline
64 & 33.0 \\
\hline
31 & 49.9 \\
\hline
81 & 52.3 \\
\hline
114 & 75.6 \\
\hline
... | PMC6079332_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
& \textbf{Provinces} & \textbf{2010} & \textbf{2011} & \textbf{2012} & \textbf{2013} & \textbf{2014} & \textbf{Total} \\
\hline
1 & Baluchestan & 10 & 35 & 20 & 142 & 3 & 210 \\
\hline
2 & South Khorasan & 0 & & 0 & 1 & 1 & 2 \\
\hline
3 & Khora... | PMC5062172_table_5 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Conse-} & \textbf{BAC library} & \textbf{EST library} \\
\hline
SSR-1 Reads • geno- & 11.89 & 26.11 \\
\hline
SSR-1 a Bases • (kb) & 7.048 & 18.49 \\
\hline
alle- \% SSR sequence & 0.27\% & 0.06\% \\
\hline
Number of repeats & 9.96 & 5.92 \\
\hline
... | PMC2996956_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{JAMA} & \textbf{HON} & \textbf{DISCERN} \\
\hline
1. Authorship 2. Source attribution 3. Ownership disclosure 4. Currency & 1. Authorship 2. Attribution 3. Privacy 4. Complementarity 5. Transparency 6. Justifiability 7. Financial disclosure 8. Adver... | PMC6158347_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{4}{|l|}{\textbf{Total (N = 60)}} & \multicolumn{4}{|l|}{\textbf{Males (N = 23)}} \\
\hline
& \textbf{NA} & \textbf{\%} & \textbf{Frequency} & \textbf{Individual} & \textbf{NA} & \textbf{\%} & \textbf{Frequency} & \textbf{Individ... | PMC2909159_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Antibodya} & \textbf{Calibratorb} & \multicolumn{3}{|l|}{\textbf{Arrayc}} \\
\hline
& & \textbf{1} & \textbf{2} & \textbf{3} \\
\hline
EGFR \#1 & 1 & 59\% & 60\% & 61\% \\
\hline
& 2 & 58\% & 58\% & 60\% \\
\hline
EGFR \#2 & 1 & 85\% & 85\% &... | PMC3022873_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{GOBPID} & \textbf{Pvalue} & \textbf{Count} & \textbf{Size} & \textbf{Term} \\
\hline
GO:0045064 & 0.010795911 & 1 & 2 & T-helper 2 cell differentiation \\
\hline
GO:0042097 & 0.010795911 & 1 & 2 & interleukin-4 biosynthesis \\
\hline
GO:0042109 ... | PMC3053315_table_7 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Variables} & \textbf{ICC} & \textbf{95\%} & \textbf{CI} & \textbf{SEM [°]} & \textbf{P value} \\
\hline
[30]. Plurimeter SS—photo SS consid- & 0.93 & 0.89 & 0.95 & 1.2 & 0.712 \\
\hline
Plurimeter LL—photo LL & 0.97 & 0.93 & 0.98 & 0.9 & 0.425... | PMC5738151_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Variables} & \textbf{1} & \textbf{2} & \textbf{3} & \textbf{4} & \textbf{5} & \textbf{6} & \textbf{7} & \textbf{8} & \textbf{9} & \textbf{10} & \textbf{11} & \textbf{12} & \textbf{13} & \textbf{14} \\
\hline
Total Score DAS &... | PMC6418016_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Medication} & \textbf{Overall Healed} & \textbf{Failed} & \textbf{Heal Rate} & \textbf{Lower CI} & \textbf{Upper CI} & \textbf{Elderly Healed} & \textbf{Failed} & \textbf{Heal Rate} \\
\hline
\\
\hline
No medications at all & 1,765 & 61... | PMC4357153_table_6 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Isolate reference} & \textbf{∗Matching nucleotides/ identity} & \textbf{∗∗Closest related species} \\
\hline
TOMC MS1 & 855 bp | 99\% & Bacillus drentensis |gi|828177967| KP407110.1 \\
\hline
TOMC MS2 & 694 bp | 99\% & Bacillus asahii |gi|238800438|... | PMC4987347_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{PON1 Premenopausal Postmenopausal Controls, Cases Controls, Cases Q192R Local, OR Advanced, OR Local, OR Advanced, OR by by (95\% (95\% (95\% (95\% n n stage stage n n (\%) (\%) (\%) (\%) CI)a CI)a CI)a CI)a n n (\%) (\%)} & \textbf{128 144 196 ... | PMC2680904_table_6 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Sample ID} & \textbf{Replication} & \textbf{Total reads clean} & \textbf{Total reads mapped} & \textbf{Perfect match} & \textbf{$<$ Mismatch =2 bp} & \textbf{Unique match} & \textbf{Multi-position match} & \textbf{Total reads unmapped} \... | PMC4982202_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Risk Factor, Exposure Metric, Data Sourcea} & \textbf{Optimal} & \textbf{Guidelines/National Goals} \\
\hline
\multicolumn{3}{|l|}{High blood glucose} \\
\hline
Fasting plasma glucose (mmol/l) & 4.9 (0.3) & 5.6 (0.3) [66] \\
\hline
\multicolumn{3}{|... | PMC3265534_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{men} & \multicolumn{2}{|l|}{\textbf{women}} \\
\hline
& & \textbf{non-pregnant} & \textbf{pregnant} & \textbf{p-value} \\
\hline
n & 10 & 10 & 10 \\
\hline
age (year) & 26 ($\pm$10) & 27 ($\pm$6) & 27 ($\pm$3) & 0.899 \\
\hline
aortic root ... | PMC5951569_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{IMD quintile} & \textbf{Female (£)} & \textbf{Male (£)} & \textbf{Total (£)} \\
\hline
Q1 (most deprived) & 1 127 006 663 & 1 065 236 932 & 2 192 243 595 \\
\hline
Q2 & 706 629 004 & 671 287 893 & 1 377 916 897 \\
\hline
Q3 & 410 841 645 & 405 654... | PMC5036206_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Treatment} & \textbf{Stage} & \multicolumn{4}{|l|}{\textbf{Response}} \\
\hline
& & \textbf{CR No. (\%)} & \textbf{PR No. (\%)} & \textbf{SD/PD No. (\%)} & \textbf{Total No. (\%)} \\
\hline
\\
\hline
RT & I & 176 (98) & 2 (1) & 1 (1) & 179 ... | PMC4492987_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{ID\#} & \textbf{ALT pre/ post-partum, Antiviral Therapy} & \textbf{P Neutral} & \textbf{P Positive} & \textbf{P Purifying} & \textbf{Selectiond} \\
\hline
128 & 15 / 17, No & 0.246 & 1.000 & 0.126 & Neutral \\
\hline
133 & 10 / 24, No & 0.075 ... | PMC4608582_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
& & \multicolumn{2}{|l|}{\textbf{Tromsø 4 (1994–1995)}} & \multicolumn{2}{|l|}{\textbf{Tromsø 6 (2007–2008)}} & \multicolumn{2}{|l|}{\textbf{Changes between Tromsø 4 and Tromsø 6}} \\
\hline
\textbf{Age in 1994 (birth year)} & \textbf{n} & \text... | PMC5031316_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Year} & \textbf{Estimated population\#} & \textbf{Birth cohort} & \textbf{Vaccination coverage*} & \textbf{Vaccine efficacy**} & \textbf{Children susceptible} & \textbf{Cumulated susceptible population} \\
\hline
1988 & 2,076,264 & 44,432 & ... | PMC1586205_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Sample biopanning used experimentsa in} & \textbf{CaSR consensus peptide sequencesb} & \textbf{residues Amino of acid CaSRc} & \textbf{consensus Number of sequence clones with (\%)} \\
\hline
APS1-2 & AQKKGDIILGGLFPIHFGVAAKDQDLKSRPESVECIRYNFRGFRWL... | PMC3153323_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
& \textbf{Liver R2(s-1)} & \textbf{Bone Marrow R2(s-1)} & \textbf{Spleen R2(s-1)} & \textbf{Kidney R2(s-1)} & \textbf{Heart R2*(s-1)} \\
\hline
Control & 33.7 $\pm$ 7.6 & 21.8 $\pm$ 4.9 & 19.6 $\pm$ 2.8 & 17.1 $\pm$ 2.9 \\
\hline
& (21–45) & (14.5–3... | PMC4583270_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Verb generation fMRI task} & \textbf{BADA stimuli} \\
\hline
Bicchiere (glass) & Versare (to pour) \\
\hline
Chitarra (guitar) & Suonare (to sing) \\
\hline
Fucile (rifle) & Sparare (to shoot) \\
\hline
Fiasco (flask) & Versare (to pour) rep \\
\hline... | PMC3675382_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Time} & \textbf{Control} & \textbf{Sw} & \textbf{DEP} & \textbf{DEP + Sw} \\
\hline
10° min & 3.5$\pm$ 1.1 & 4.1$\pm$ 0.7 & 4.4$\pm$ 1.4 & 3.7$\pm$ 1.6 \\
\hline
30° min & 5.6$\pm$ 1.4* & 5.9$\pm$ 0.3* & 6.2$\pm$ 1.2* & 5.7$\pm$ 0.8* \\
\hline
\... | PMC4557939_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Reasons} & \textbf{N\% out of 36 subjects} & \textbf{N\% out of 216 subjects} \\
\hline
Heavy personal activity load & 10 (27.8) & 10 (4.6) \\
\hline
Poor health & 16 (44.4) & 16 (7.4) \\
\hline
Caregiver for sick husband or wife & 4 (11.1) & 4 (1.9... | PMC3607803_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{IL-2} & \textbf{IL-2+ART} & \textbf{Control} & \textbf{Total} \\
\hline
\multicolumn{5}{|l|}{Age (years)} \\
\hline
Median & 35 & 35 & 36 & 36 \\
\hline
Interquartile range & & & & 30–44 \\
\hline
Gender (\% female) & 19.1 & 14.9 & 17.6 & ... | PMC2826395_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\multicolumn{2}{|l|}{were P. falciparum} \\
\hline
18S rRNA & Pf_18S rRNA‑F: AATAACAATGCAAGGCCAATTT \\
\hline
P. & Pf_18S rRNA‑R: CTGCAACAATTTTAATATACGC \\
\hline
LDH & Pf_LDH‑F: AAACCCAGTAGATGTTATGGTAC \\
\hline
the & Pf_LDH‑R: CATTTTATTTCCATGAGCACCTAC \\
\h... | PMC4784371_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{C∗} & \textbf{C∗) C1 and (C10 +} & \textbf{C∗) (C1 + and C10} \\
\hline
C3 & 0.841 & 0.968 \\
\hline
C2 & 0.880 & 0.810 \\
\hline
\end{tabular}}
\end{table} | PMC4866020_table_5 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
Atom Mn, & Site & Present work & al.1) Dominko et & al.2) Arroyo-de Dompablo et \\
\hline
Li & 4b & 1.02 (6) & 1.0 (1) & 0.9 \\
\hline
Poly- Mn & 2a & 1.89 (5) & 2.1 (1) & 1.77 \\
\hline
Si & 2a & 3.89 (7) & 3.6 (2) & 3.65 \\
\hline
O1 & 2a & 2.02 (9) &... | PMC3435565_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Sample} & \textbf{Identified proteins} & \textbf{Accession number} & \textbf{Seq. Cov. [\%]} & \textbf{Matching Peptides} & \textbf{Unique Peptides*} & \textbf{Position} & \textbf{Score} & \textbf{Species} \\
\hline
Stick 1 (from M17) & ... | PMC4730899_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{SCN5A (n = 40) positive} & \textbf{SCN5A (n = 98) negative} & \textbf{Volunteers (n = 18)} & \textbf{P SCN5A value* negative SCN5A positive vs.} \\
\hline
Age, years & 45.1614.3 & 43.9612.5 & 42.068.7 & 0.77 \\
\hline
Sex, man/woman (n) & 22/... | PMC3410911_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Case type} & \textbf{Broad diagnosis} & \textbf{Main reason for admission} & \textbf{Challenging behaviour} & \textbf{Resident carer} & \textbf{\% Appropriateness score} \\
\hline
1 & Depression/anxiety & Risk of deliberate self-harm & Low & Y... | PMC4504087_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
& & \multicolumn{4}{|l|}{\textbf{Feeling scale}} & \multicolumn{4}{|l|}{\textbf{Felt arousal scale}} \\
\hline
& & \textbf{Mean} & \textbf{SEM} & \textbf{Median} & \textbf{IQR} & \textbf{Mean} & \textbf{SEM} & \textbf{Median} & \textbf{IQR... | PMC6232759_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
& \textbf{Group A (n = 35)} & \textbf{Group G (n = 35)} & \textbf{P-value} \\
\hline
Age (years) & 56 $\pm$ 15 (19–75) & 55 $\pm$ 13 (24–75) & 0.772 \\
\hline
Gender (male/female, n) & 22/13 & 21/14 & 0.811 \\
\hline
Weight (Kg) & 64.6 $\pm$ 12.2 (44–87)... | PMC4419514_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
& \textbf{Cont 3 M} & \textbf{Cont 6 M} & \textbf{Cont 11 M} & \textbf{Cont 21 M} & \textbf{Inulin 3 M} & \textbf{Inulin 6 M} & \textbf{Inulin 11 M} & \textbf{Inulin 21 M} & \textbf{inulin} & \textbf{age} & \textbf{interaction} \\
\hline
... | PMC1283151_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
& \textbf{U11} & \textbf{U22} & \textbf{U33} & \textbf{U12} & \textbf{U13} & \textbf{U23} \\
\hline
C1 & 0.0323 (12) & 0.0467 (13) & 0.0504 (14) & 0.0078 (10) & 0.0086 (10) & 0.0101 (11) \\
\hline
N1 & 0.0608 (16) & 0.0709 (16) & 0.0496 (14) & 0.00... | PMC3099801_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Immunoreactivitya} & \textbf{0\%} & \textbf{$\leq$50\%} & \textbf{$>$50\%} & \textbf{t-test} \\
\hline
p63 in normal ductsb & 0 & 0 & 100\% \\
\hline
p63 in DCIS & 4\% & 52\% & 44\% & p=.01 \\
\hline
CD31 in normal vessels & 0 & 0 & 100\% \\
\hl... | PMC3058877_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{COG id} & \textbf{Description} & \multicolumn{2}{|l|}{\textbf{Mature}} & \multicolumn{2}{|l|}{\textbf{Infant}} & \textbf{Metastat value q-} \\
\hline
& & \textbf{Mean abundance (\%)} & \textbf{stderr} & \textbf{Mean abundance (\%)} & \text... | PMC2661018_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Subtype} & \textbf{Negative n (\%)} & \textbf{Positive n (\%)} & \textbf{Total n (\%)} \\
\hline
Luminal & 21 (55.3\%) & 17 (44.7\%) & 38 (100\%) \\
\hline
Basal & 0 (.0\%) & 1 (100.0\%) & 1 (100\%) \\
\hline
HER2 & 7 (43.8\%) & 9 (56.2\%) & 16 (1... | PMC3109576_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Condition} & \textbf{Qv (g SA/L.h)} & \textbf{Qp (mg SA/g cell mass.h)} & \textbf{Y(X/S) (g/100 g)} & \textbf{Y(P/S) (g/100 g)} \\
\hline
Wild type & 0.01 & 8.83 & 25 & 2.65 \\
\hline
Recombinant & 0.08 & 26.31 & 33.25 & 21 \\
\hline
Fold & 8 & ... | PMC4490670_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\multicolumn{11}{|l|}{amplitude(uV)} \\
\hline
& a-wave & p value & b-wave & p value & on-PhNR & p value & d-wave & p value & off-PhNR & p value \\
\hline
pre & 21.35$\pm$7.08 & 0.48470677 & 43.35$\pm$14.14 & 0.11985184 & 28.3$\pm$13.58 & 0... | PMC4806841_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Class} & \textbf{Total} \\
\hline
Synonymous SNPs & 11,155 \\
\hline
\multicolumn{2}{|l|}{Non-synonymous SNPs} \\
\hline
Missense type & 11,107 \\
\hline
Non-sense type & 109 \\
\hline
\multicolumn{2}{|l|}{Coding-region Indels} \\
\hline
In-frame Inde... | PMC3534380_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Risk of dissatisfaction} & \textbf{Public (\%)} & \textbf{Private (\%)} & \textbf{All (\%)} \\
\hline
Properly identified specimen & 3/10(30.0) & 1/4(25.0) & 4/14(28.6) \\
\hline
Clear and accurate test request & 4/10 (40.0) & 2/4(50.0) & 6/14(42.... | PMC2518553_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Average measures} & \textbf{Intraclass correlation} & \multicolumn{2}{|l|}{\textbf{95\% confidence interval}} & \multicolumn{4}{|l|}{\textbf{F test with true value 0}} \\
\hline
& & \textbf{Lower bound} & \textbf{Upper bound} & \textbf{F... | PMC5662710_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Metrics} & \textbf{stroma} & \textbf{Benign hyperplasia} & \textbf{intraepithelial neoplasia} & \textbf{carcinoma} \\
\hline
Jaccard-similarity-coefficient & 80 & 76 & 75 & 82 \\
\hline
Dice-similarity-coefficient & 87 & 86 & 86 & 89 \\
\hline
F... | PMC5893871_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& \textbf{Yes} & \textbf{No} & \textbf{Unclear} & \textbf{Comments} \\
\hline
1. Was the randomisation procedure adequate? & ☐ & ☐ & ☐ \\
\hline
2. Was the treatment allocation adequately concealed? & ☐ & ☐ & ☐ \\
\hline
3. Were participants blinded to... | PMC5084436_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Profiles} & \textbf{Characterization of the cluster defining the profile} \\
\hline
Professional & contacts at work have highest median as compared to other locations: m11 = max {m1i:i = 1,…,6} \\
\hline
School & contacts at school have highest median... | PMC2691957_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Groups} & \multicolumn{2}{|l|}{\textbf{LDH level IU/L}} & \textbf{Percent of changing} \\
\hline
& \textbf{Before treatment} & \textbf{After treatment} \\
\hline
Doxorubicin 15 mg./kg & 578.8 $\pm$ 72.3 & 4328.1 $\pm$ 209.5 ††** & 647\% \\
\hline... | PMC3483230_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\multicolumn{2}{|l|}{\textbf{Findings}} & \multicolumn{2}{|l|}{\textbf{Patients}} \\
\hline
& & \textbf{\#} & \textbf{\% 1} \\
\hline
Respiratory & Pneumonia & 69 & 63.9 \\
\hline
& Pleural effusion & 12 & 11.1 \\
\hline
& Exacerbated COPD/Asthma & 24... | PMC3419232_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{5}{|l|}{\textbf{Female respondents (n = 355)}} & \multicolumn{5}{|l|}{\textbf{Male respondents (n = 488)}} \\
\hline
& \textbf{1} & \textbf{2} & \textbf{3} & \textbf{4} & \textbf{5} & \textbf{1} & \textbf{2} & \textbf{3} & \... | PMC4348469_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
& \multicolumn{3}{|l|}{\textbf{S1}} & \multicolumn{3}{|l|}{\textbf{S2}} & \multicolumn{3}{|l|}{\textbf{S3}} \\
\hline
& \textbf{With FNS} & \textbf{Without FNS} & \textbf{P-value} & \textbf{With FNS} & \textbf{Without FNS} & \textbf{P-value}... | PMC5848592_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& & \textbf{CBP statistics: Punctual vs Iterative} & \textbf{GLM statistics: Punctual context} & \textbf{GLM statistics: Iterative context} \\
\hline
1 & Now position (Time: 600–800 ms, Frequency: 60–80 Hz) & tsum p = 798.09, = 0.012, S = 535 & t p = ... | PMC4395362_table_2 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Location} & \textbf{Trial(s)} & \textbf{df1} & \textbf{df2a} & \textbf{F statistic} & \textbf{p-value} & \textbf{Difference b (degrees)} \\
\hline
Inland & All trials & 1 & 119,998 & 740 & $\leq$ 0.001 & 11.11 \\
\hline
& Trial A & 1 & 39,9... | PMC6114834_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
& \textbf{Administrator at regional/county level n = 20 (\%)} & \textbf{Health care personnel at health centers n = 315 (\%)} \\
\hline
\multicolumn{3}{|l|}{Sex} \\
\hline
Female & 16 (80.0) & 247(78.4) \\
\hline
Male & 4 (20.0) & 58 (18.4) \\
\hline
Missi... | PMC6199803_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|}
\hline
\textbf{Treatment Group} & \textbf{Time Post-Exposure} & \textbf{AII} & \textbf{BI} & \textbf{TBI} & \textbf{BHH} \\
\hline
Gr20 & 7 day & - & 0.17 (1/6) & 1.7 (6/6) & 1.0 (5/6) \\
\hline
Gr5 & 7 day & - & - & 1.0 (5/6) & - \\
\hline
Gr1 & 7 day & - &... | PMC4915050_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Source} & \multicolumn{2}{|l|}{\textbf{dChip}} & \multicolumn{2}{|l|}{\textbf{MAS 5.0}} & \multicolumn{2}{|l|}{\textbf{RMA}} & \multicolumn{2}{|l|}{\textbf{GCRMA-EB}} \\
\hline
& \textbf{Mean} & \textbf{SD} & \textbf{Mean} & \textbf{SD}... | PMC1232851_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|}
\hline
\textbf{Domain} & \textbf{Criteria} \\
\hline
Qualification & At least 10 years of formal education (equivalent to GCSE) \\
\hline
Experience & Socio-demographic background and life experiences similar to that of the target population \\
\hline
& Emotional m... | PMC4793537_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Bacteria isolates} & \textbf{N} & \textbf{n(\%) GEN} & \textbf{n(\%) CRX} & \textbf{CHLO n(\%)} & \textbf{n(\%) CTR} & \textbf{n(\%) CTX} & \textbf{AMP n(\%)} & \textbf{n(\%) TET} & \textbf{n(\%) COT} & \textbf{n(\%) PEN} & \text... | PMC3598494_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Species} & \textbf{Date} & \textbf{Tstart [°C]} & \textbf{WR [K·h−1]} & \textbf{Texp [°C]} & \textbf{Tc [°C]} & \textbf{LT5 [°C]} & \textbf{T [°C]} & \textbf{PPFD} \\
\hline
Rhododendron ferrugineum & 9 August 2012 & 30 & 6.5 & 43 & 44 &... | PMC4407927_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Gene symbol} & \textbf{Direction} & \textbf{Primer sequence} & \textbf{Amplicon size} \\
\hline
AMR & Forward & GTGCATGCCATTGCCTAGCTGA & 78 \\
\hline
& Reverse & TCATTTCCGGTGTGGCTTGGCA \\
\hline
Bax & Forward & CCAGGACGCATCCACCAAGAAGC & 136 \\
\h... | PMC4440734_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
& & \multicolumn{3}{|l|}{\textbf{12:00}} \\
\hline
& & \textbf{Max} & \textbf{Middle} & \textbf{Min} \\
\hline
14:00 & Max & 0.993 & 0.977 & 0.986 \\
\hline
& Middle & 0.966 & 0.997 & 0.957 \\
\hline
& Min & 0.993 & 0.972 & 0.991 \\
\hline
\end{ta... | PMC5750798_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Gene} & \textbf{Primer} & \textbf{Sequence (5’-3’)} & \textbf{Number of CpGs} \\
\hline
FOXP3 & forward & Biotin-AGTTTGGTTTGTGGGAAATTGTT \\
\hline
& reverse & ACCCTATTATCTCATTAATACCTCTCA \\
\hline
& Sequence 1 & ATAAAAACAAAATTATTTTTAATA & 1 \\
\... | PMC4928917_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Prot. name PDB ID basic(acid)} & \textbf{Protein family} & \textbf{Resolution basic(acid)} & \textbf{H-bond residues} & \textbf{H-bond distances basic(acid)} & \textbf{p/p interactions residues} & \textbf{p/p interactions distances basic(aci... | PMC4518280_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{Variable/Areas Women} & \textbf{Formal (n = 153)} & \textbf{Informal (n = 297)} & \textbf{Total (n = 450)} & \textbf{P} \\
\hline
\\
\hline
Fruits, n (\%) & & & & 0.310c \\
\hline
Daily & 87 (56.9) & 184 (62.0) & 271 (60.2) \\
\hline
Others ... | PMC6085717_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|}
\hline
\textbf{CTS grade} & \textbf{Mild (n = 11)} & \textbf{Moderate (n = 55)} & \textbf{Total (n = 66)} & \textbf{P-value} \\
\hline
Age, years & 46[15] & 50[13] & 50[13] & 0.67 \\
\hline
Sex, F/M & 11/0 & 39/16 & 50/16 & 0.05 \\
\hline
Bilat./unilat. & 2/9 ... | PMC5721389_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|}
\hline
\textbf{Model} & \textbf{WAIC} & \textbf{WAIC SE} & \textbf{$\Delta$ WAIC} \\
\hline
JC & 27548.3 & 92.0207 & 0 \\
\hline
SD & 27571.1 & 92.7548 & 22.8124 \\
\hline
TD & 27741.6 & 93.5845 & 193.243 \\
\hline
TSW & 27749.5 & 93.3275 & 201.18 \\
\hline
SW &... | PMC5993323_table_3 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Reported motif} & \textbf{Dennis} & \textbf{Ozsolak} \\
\hline
AAAA/TTTT & 37 & 36 \\
\hline
AAAT & 26 & 28 \\
\hline
AATA & 7 & 6 \\
\hline
ATAA & 5 & 4 \\
\hline
GAAA & 37 & 38 \\
\hline
ATTA & 2 & 8 \\
\hline
TATA & 1 & 1 \\
\hline
AATT & 6 & 19 ... | PMC3213122_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Category \# Term} & \textbf{Job title} & \textbf{\# of participants interviewed} \\
\hline
1 These & Laboratory Manager & 3 \\
\hline
2 & Transfusion Safety Officer & 2 \\
\hline
3 blood & Lab Technologist (Blood Bank) & 9 \\
\hline
4 to & Physician... | PMC3223866_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
\textbf{Variable} & \multicolumn{4}{|l|}{\textbf{Total Sample}} & \multicolumn{4}{|l|}{\textbf{Public Sector}} & \multicolumn{4}{|l|}{\textbf{Private Sector}} \\
\hline
& \textbf{M} & \textbf{SD} & \textbf{2} & \textbf{3} & \textbf{M} &... | PMC6068656_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\textbf{Gene symbol} & \textbf{C vs. MH1} & \textbf{C vs. MH2} & \textbf{C vs. SH1} & \textbf{C vs. SH2} & \textbf{C vs. SHW1} & \textbf{C vs. SHW2} \\
\hline
AMR & p = 0.004 & p = 0.001 & & & p = 0.001 & p = 0.008 \\
\hline
Bax & p = 0.048 & p = ... | PMC4440734_table_1 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Genotype} & \textbf{Rooting (\%)} & \textbf{No. roots} \\
\hline
3M & 98az & 17.0a \\
\hline
C10 & 100a & 14.5ab \\
\hline
B6 & 100a & 9.6bc \\
\hline
MP11 & 78b & 6.2c \\
\hline
\end{tabular}}
\end{table} | PMC5881154_table_4 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|}
\hline
\textbf{Species} & \textbf{Latin name} & \textbf{Counts} \\
\hline
Ginseng Radix et Rhizoma & Panax ginseng C. A. Me & 79943 \\
\hline
Achyranthis bidentatae Radix & Achyranthes bidentata B1. & 157189 \\
\hline
Glycyrrhiz Radix et Rhizoma & Glycyrrhiza ural... | PMC5974330_table_0 | |
\begin{table}
\scalebox{0.60}{
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
\textbf{Pop} & & \textbf{N} & \textbf{Na} & \textbf{Ne} & \textbf{Ho} & \textbf{He} & \textbf{F} \\
\hline
Normal & Mean & 148 & 5.939 & 3.230 & 0.612 & 0.638 & 0.038 \\
\hline
& SE & & 0.351 & 0.212 & 0.027 & 0.028 & 0.011 \\
\hline
Normal + c... | PMC5699110_table_5 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.